225 related articles for article (PubMed ID: 27765766)
1. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
[TBL] [Abstract][Full Text] [Related]
2. Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.
Zhou Y; Abraham S; Andre P; Edelstein LC; Shaw CA; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
Blood; 2015 Dec; 126(26):2871-81. PubMed ID: 26516227
[TBL] [Abstract][Full Text] [Related]
3. An α
Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.
Rollin J; Pouplard C; Gratacap MP; Leroux D; May MA; Aupart M; Gouilleux-Gruart V; Payrastre B; Gruel Y
Blood; 2012 Aug; 120(6):1309-16. PubMed ID: 22677127
[TBL] [Abstract][Full Text] [Related]
5. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.
Yeung J; Tourdot BE; Fernandez-Perez P; Vesci J; Ren J; Smyrniotis CJ; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; McKenzie SE; Holinstat M
Blood; 2014 Oct; 124(14):2271-9. PubMed ID: 25100742
[TBL] [Abstract][Full Text] [Related]
6. A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets.
Thomas DH; Getz TM; Newman TN; Dangelmaier CA; Carpino N; Kunapuli SP; Tsygankov AY; Daniel JL
Blood; 2010 Oct; 116(14):2570-8. PubMed ID: 20585042
[TBL] [Abstract][Full Text] [Related]
7. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
8. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model.
McKenzie SE; Taylor SM; Malladi P; Yuhan H; Cassel DL; Chien P; Schwartz E; Schreiber AD; Surrey S; Reilly MP
J Immunol; 1999 Apr; 162(7):4311-8. PubMed ID: 10201963
[TBL] [Abstract][Full Text] [Related]
9. FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation.
Gratacap MP; Hérault JP; Viala C; Ragab A; Savi P; Herbert JM; Chap H; Plantavid M; Payrastre B
Blood; 2000 Nov; 96(10):3439-46. PubMed ID: 11071639
[TBL] [Abstract][Full Text] [Related]
10. Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.
Arman M; Krauel K
J Thromb Haemost; 2015 Jun; 13(6):893-908. PubMed ID: 25900780
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3.
Pampolina C; McNicol A
Thromb Haemost; 2005 May; 93(5):932-9. PubMed ID: 15886812
[TBL] [Abstract][Full Text] [Related]
12. Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.
Gao C; Boylan B; Bougie D; Gill JC; Birenbaum J; Newman DK; Aster RH; Newman PJ
J Clin Invest; 2009 Mar; 119(3):504-11. PubMed ID: 19197137
[TBL] [Abstract][Full Text] [Related]
13. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.
Boylan B; Gao C; Rathore V; Gill JC; Newman DK; Newman PJ
Blood; 2008 Oct; 112(7):2780-6. PubMed ID: 18641368
[TBL] [Abstract][Full Text] [Related]
14. Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition.
Renna SA; Zhao X; Kunapuli SP; Ma P; Holinstat M; Boxer MB; Maloney DJ; Michael JV; McKenzie SE
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1808-1817. PubMed ID: 37345522
[TBL] [Abstract][Full Text] [Related]
15. The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of FcgammaRIIA-mediated cell activation.
Mancini F; Rigacci S; Berti A; Balduini C; Torti M
Blood; 2007 Sep; 110(6):1871-8. PubMed ID: 17537991
[TBL] [Abstract][Full Text] [Related]
16. Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
Zhi H; Rauova L; Hayes V; Gao C; Boylan B; Newman DK; McKenzie SE; Cooley BC; Poncz M; Newman PJ
Blood; 2013 Mar; 121(10):1858-67. PubMed ID: 23264598
[TBL] [Abstract][Full Text] [Related]
17. The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.
Lhermusier T; van Rottem J; Garcia C; Xuereb JM; Ragab A; Martin V; Gratacap MP; Sié P; Payrastre B
J Thromb Haemost; 2011 Oct; 9(10):2067-76. PubMed ID: 21848694
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA.
Reilly MP; Taylor SM; Hartman NK; Arepally GM; Sachais BS; Cines DB; Poncz M; McKenzie SE
Blood; 2001 Oct; 98(8):2442-7. PubMed ID: 11588041
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
20. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia.
Brandt JT; Isenhart CE; Osborne JM; Ahmed A; Anderson CL
Thromb Haemost; 1995 Dec; 74(6):1564-72. PubMed ID: 8772238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
